Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma

Experimental Hematology

Volumn 37, Issue 11, 2009, Pages 1295-1309

  Sniderhan, Lynn F ^a   Garcia Bates, Tatiana M ^a   Burgart, Michael ^a   Bernstein, Steven H ^a   Phipps, Richard P ^a   Maggirwar, Sanjay B ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; K 252A; LIPOCORTIN 5; NEUROTROPHIN; PROPIDIUM IODIDE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; TRANSCRIPTION FACTOR RELA; TROPOMYOSIN RECEPTOR KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LARGE CELL LYMPHOMA; LYMPHOMA CELL; NONHODGKIN LYMPHOMA; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; AUTOCRINE COMMUNICATION; B-LYMPHOCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARBAZOLES; CELL DIVISION; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; DNA REPLICATION; HUMANS; INDOLE ALKALOIDS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; NEOPLASM PROTEINS; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NF-KAPPA B; RECEPTORS, NERVE GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TYRPHOSTINS;

EID: 70349792164     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.08.005     Document Type: Article

References (52)

1. Fisher R.I., and Shah P. Current trends in large cell lymphoma. Leukemia 17 (2003) 1948-1960
2. Dave S.S., Wright G., Tan B., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351 (2004) 2159-2169
3. Rosenwald A., and Staudt L.M. Gene expression profiling of diffuse large B-cell lymphoma. Leuk Lymphoma 44 Suppl 3 (2003) S41-S47
4. Hunt K.E., and Reichard K.K. Diffuse large B-cell lymphoma. Arch Pathol Lab Med 132 (2008) 118-124
5. Dionne C.A., Camoratto A.M., Jani J.P., et al. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). Clin Cancer Res 4 (1998) 1887-1898
6. Brodeur G.M., Nakagawara A., Yamashiro D.J., et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol 31 (1997) 49-55
7. Martin-Zanca D., Mitra G., Long L.K., and Barbacid M. Molecular characterization of the human trk oncogene. Cold Spring Harb Symp Quant Biol 51 Pt 2 (1986) 983-992
8. Ehrhard P.B., Erb P., Graumann U., and Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A 90 (1993) 10984-10988
9. Melamed I., Kelleher C.A., Franklin R.A., et al. Nerve growth factor signal transduction in human B lymphocytes is mediated by gp140trk. Eur J Immunol 26 (1996) 1985-1992
10. Torcia M., Bracci-Laudiero L., Lucibello M., et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85 (1996) 345-356
11. Kronfeld I., Kazimirsky G., Gelfand E.W., and Brodie C. NGF rescues human B lymphocytes from anti-IgM induced apoptosis by activation of PKCzeta. Eur J Immunol 32 (2002) 136-143
12. Jost P.J., and Ruland J. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 109 (2007) 2700-2707
13. Bargou R.C., Emmerich F., Krappmann D., et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100 (1997) 2961-2969
14. Lam L.T., Davis R.E., Pierce J., et al. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res 11 (2005) 28-40
15. Sanchez J.F., Sniderhan L.F., Williamson A.L., Fan S., Chakraborty-Sett S., and Maggirwar S.B. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling. Mol Cell Biol 23 (2003) 4649-4662
16. Zand M.S., Bose A., Vo T., et al. A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity. Am J Transplant 5 (2005) 76-86
17. D'Onofrio M., de Grazia U., Morrone S., et al. Expression of neurotrophin receptors in normal and malignant B lymphocytes. Eur Cytokine Netw 11 (2000) 283-291
18. Schenone A., Gill J.S., Zacharias D.A., and Windebank A.J. Expression of high- and low-affinity neurotrophin receptors on human transformed B lymphocytes. J Neuroimmunol 64 (1996) 141-149
19. Limpert A.S., Karlo J.C., and Landreth G.E. Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signal-regulated kinase activation through c-Cbl-associated protein. Mol Cell Biol 27 (2007) 5686-5698
20. Li H., Ayer L.M., Polyak M.J., et al. The CD20 calcium channel is localized to microvilli and constitutively associated with membrane rafts: antibody binding increases the affinity of the association through an epitope-dependent cross-linking-independent mechanism. J Biol Chem 279 (2004) 19893-19901
21. Cherukuri A., Shoham T., Sohn H.W., et al. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J Immunol 172 (2004) 370-380
22. Labouyrie E., Parrens M., de Mascarel A., Bloch B., and Merlio J.P. Distribution of NGF receptors in normal and pathologic human lymphoid tissues. J Neuroimmunol 77 (1997) 161-173
23. Ohmichi M., Pang L., Ribon V., Gazit A., Levitzki A., and Saltiel A.R. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor. Biochemistry 32 (1993) 4650-4658
24. Cillessen S.A., Hess C.J., Hooijberg E., et al. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma. Clin Cancer Res 13 (2007) 7012-7021
25. Kerschensteiner M., Gallmeier E., Behrens L., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J Exp Med 189 (1999) 865-870
26. Belmont A. Dynamics of chromatin, proteins, and bodies within the cell nucleus. Curr Opin Cell Biol 15 (2003) 304-310
27. Sui Z., Sniderhan L.F., Fan S., et al. Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. Eur J Neurosci 23 (2006) 2623-2634
28. Gruss H.J., Ulrich D., Dower S.K., Herrmann F., and Brach M.A. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor. Blood 87 (1996) 2443-2449
29. Keller S.A., Hernandez-Hopkins D., Vider J., et al. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 107 (2006) 3295-3302
30. Yee C., Biondi A., Wang X.H., et al. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 74 (1989) 798-804
31. Collins C., Carducci M.A., Eisenberger M.A., et al. Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint. Cancer Biol Ther 6 (2007) 1360-1367
32. Kase H., Iwahashi K., and Matsuda Y. K-252a, a potent inhibitor of protein kinase C from microbial origin. J Antibiot (Tokyo) 39 (1986) 1059-1065
33. Tapley P., Lamballe F., and Barbacid M. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene 7 (1992) 371-381
34. Berg M.M., Sternberg D.W., Parada L.F., and Chao M.V. K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem 267 (1992) 13-16
35. von Bartheld C.S., Williams R., Lefcort F., Clary D.O., Reichardt L.F., and Bothwell M. Retrograde transport of neurotrophins from the eye to the brain in chick embryos: roles of the p75NTR and trkB receptors. J Neurosci 16 (1996) 2995-3008
36. Caldeira M.V., Melo C.V., Pereira D.B., et al. Brain-derived neurotrophic factor regulates the expression and synaptic delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons. J Biol Chem 282 (2007) 12619-12628
37. Merighi A., Bardoni R., Salio C., et al. Presynaptic functional trkB receptors mediate the release of excitatory neurotransmitters from primary afferent terminals in lamina II (substantia gelatinosa) of postnatal rat spinal cord. Dev Neurobiol 68 (2008) 457-475
38. Iwakura Y., Nawa H., Sora I., and Chao M.V. Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. J Biol Chem 283 (2008) 15799-15806
39. Bozdagi O., Rich E., Tronel S., et al. The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J Neurosci 28 (2008) 9857-9869
40. Nguyen N., Lee S.B., Lee Y.S., Lee K.H., and Ahn J.Y. Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 34 (2009) 942-951
41. Cordon-Cardo C., Tapley P., Jing S.Q., et al. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 66 (1991) 173-183
42. Takai N., Ueda T., Nishida M., Nasu K., and Narahara H. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells. Oncol Rep 19 (2008) 749-753
43. Takai N., Ueda T., Nishida M., Nasu K., Fukuda J., and Miyakawa I. K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1. Oncol Rep 14 (2005) 141-143
44. Delsite R., and Djakiew D. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines. J Androl 17 (1996) 481-490
45. Perez-Pinera P., Hernandez T., Garcia-Suarez O., et al. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas. Mol Cell Biochem 295 (2007) 19-26
46. Chin L.S., Murray S.F., Doherty P.F., and Singh S.K. K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c. Cancer Invest 17 (1999) 391-395
47. Rocha S., Garrett M.D., Campbell K.J., Schumm K., and Perkins N.D. Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 24 (2005) 1157-1169
48. Birbach A., Bailey S.T., Ghosh S., and Schmid J.A. Cytosolic, nuclear and nucleolar localization signals determine subcellular distribution and activity of the NF-kappaB inducing kinase NIK. J Cell Sci 117 (2004) 3615-3624
49. Thoms H.C., Dunlop M.G., and Stark L.A. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res 67 (2007) 1660-1669
50. Thoms H.C., Dunlop M.G., and Stark L.A. CDK4 inhibitors and apoptosis: a novel mechanism requiring nucleolar targeting of RelA. Cell Cycle 6 (2007) 1293-1297
51. Rosini P., De Chiara G., Lucibello M., Garaci E., Cozzolino F., and Torcia M. NGF withdrawal induces apoptosis in CESS B cell line through p38 MAPK activation and Bcl-2 phosphorylation. Biochem Biophys Res Commun 278 (2000) 753-759
52. Kummer J.L., Rao P.K., and Heidenreich K.A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 272 (1997) 20490-20494